Viracyte, LLC is a biotechnology company based in Saint Paul, MN that specializes in the development of virus-specific T cell (VST) therapy candidates. Their proprietary platform focuses on creating off-the-shelf VSTs to restore immunity in patients with T cell deficiencies, targeting 11 different devastating viruses for treatment or prevention.
With a mission to serve patients at risk of severe viral diseases, Viracyte is dedicated to creating innovative T cell therapies. Their team of experts is committed to advancing the field of viral infection treatment through their research, clinical trials, and publications, aiming to provide effective solutions for patients in need.
Generated from the website